Intravitreal conbercept injection for neovascular age-related macular degeneration
AIM: To evaluate the efficacy and safety of intravitreal injection of conbercept in patients with neovascular age-related macular degeneration (AMD). METHODS: Retrospective review of 66 eyes of 63 patients with neovascular AMD. All patients received 0.5 mg intravitreal injections of conbercept mont...
Main Authors: | Bing-Hui Wu, Bing Wang, Hui-Qin Wu, Qin Chang, Hui-Qin Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2019-02-01
|
Series: | International Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.ijo.cn/en_publish/2019/2/20190211.pdf |
Similar Items
-
Intravitreal injection of Conbercept in the treatment of exudative age-related macular degeneration
by: Hong-Xia Niu, et al.
Published: (2018-09-01) -
Clinical study of Conbercept intravitreal injection for the treatment of wet age-related macular degeneration
by: Xu-Ting He, et al.
Published: (2015-09-01) -
Clinical observation of intravitreal injection of Conbercept treating exudative age-related macular degeneration
by: Wei Song, et al.
Published: (2016-07-01) -
Comparison of curative effects of intravitreal injection of Ranibizumab and Conbercept in the treatment of diabetic macular edema
by: Yang Guo, et al.
Published: (2018-01-01) -
Efficacy of intravitreal Conbercept injection for macular edema secondary to macular branch retinal vein occlusion
by: Ping-Li Zhu, et al.
Published: (2018-01-01)